Hellocare
Venture Round in 2025
Hellocare is a comprehensive telehealth and virtual healthcare delivery platform that integrates software, hardware, and artificial intelligence. The company offers a range of services, including home care, primary care, virtual patient observation, remote patient monitoring, and telemedicine solutions. Its technology facilitates remote examinations and includes telemedicine carts, alerting systems, communications tools, and workflow management features. This allows healthcare providers to deliver their services from virtually any location, enhancing access to medical care for patients.
LucyRx is a pharmacy benefit manager (PBM) that aims to revolutionize prescription care. It offers a comprehensive suite of services, including personalized prescription management, transparent pricing, optimized health plans, 24/7 assistance, medication advice, and health wellness tips. By providing enhanced disclosure and simplifying claims processing, LucyRx addresses market gaps through its personal service model, ultimately helping clients better manage prescription drug costs.
Lumata Health
Series B in 2025
Lumata Health is a technology-driven healthcare startup dedicated to preventing blindness caused by chronic eye conditions. Founded in 2017 by Stephen R. Fransen, an experienced ophthalmologist and retina specialist, the company manages thousands of patients at risk of vision loss in the United States. Lumata Health employs a human-led care coordination and management platform that is typically free for patients. By collaborating with physicians, payers, and health systems, Lumata Health provides comprehensive care management services delivered by eye care experts, enhanced by advanced technology and data science. The company focuses on improving clinical outcomes, patient satisfaction, and clinic staff efficiency through proactive patient assistance and care coordination for conditions such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye. By identifying and addressing barriers to treatment adherence, Lumata Health aims to support patients in their recovery from chronic eye care challenges.
Proximity
Seed Round in 2025
Proximity is a company that specializes in providing an automation platform aimed at enhancing the revenue generated from the 340B drug discount program for eligible healthcare providers. By streamlining processes and improving efficiency, Proximity assists healthcare organizations in maximizing their financial benefits from this program, ultimately supporting their ability to serve patients effectively.
Sware specializes in providing a validation automation platform along with managed services programs designed to help companies ensure compliance with both domestic and international regulatory requirements. The company's offerings include quality management implementation and remediation, risk management, auditing and training, and computer systems validation. Through these services, Sware enables clients to achieve product efficiency and cost reduction by streamlining the systems implementation process and utilizing an integrated compliance ecosystem methodology.
Huddle Up
Series C in 2024
Huddle Up is a pediatric digital health company dedicated to supporting the growth, development, and mental health of children. Founded in 2015 and based in Madison, Wisconsin, Huddle Up transforms the care experience by emphasizing peer-to-peer interactions and specialty support. The company partners with school districts to promote academic performance and facilitate social-emotional development, while also focusing on community, equity, inclusion, and belonging. Through its personalized, outcome-driven approach, Huddle Up aims to enhance the well-being of children and adolescents, fostering healthier lives.
Greater Good Health
Series A in 2023
Greater Good Health is a healthcare organization focused on enhancing access to value-based, holistic primary care, particularly in underserved and rural communities. The company operates a nurse practitioner-led model that collaborates with health plans to establish primary care practices and works with risk-bearing organizations to implement private-labeled clinical programs aimed at promoting outcomes-focused care. By providing nurse practitioners with a comprehensive suite of resources and tools, Greater Good Health empowers them to deliver quality, whole-person care to their patients. This innovative approach not only aims to improve health outcomes and patient experiences but also to reduce healthcare costs for providers and payers.
Diana Health
Series B in 2023
Diana Health is a network of contemporary women's health practices focused on transforming the delivery of maternity and women's healthcare in collaboration with hospitals. The company aims to empower women by offering a personalized and comprehensive care model that places them at the center of decision-making. Diana Health provides an individualized care program that integrates clinical care, education, and wellness support, supplemented by a user-friendly technology platform designed to enhance health outcomes and streamline operations. By engaging women and families, Diana Health strives to create a better care experience and improve clinical outcomes, assisting women in preparing for their birth experiences and parenting journeys.
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.
Cortica Inc. is an Israeli company founded in 2007 that specializes in image understanding solutions through advanced artificial intelligence technology. With a unique self-learning system supported by over 200 patents, Cortica has developed products capable of interpreting visual content at a human-like level, surpassing the capabilities of major tech companies. Its Image2Text technology extracts context from images and videos, identifying products, brands, and abstract concepts, and linking them to relevant keywords and advertisements. This innovative approach enables Cortica to impact various industries, including autonomous vehicles, smart city applications, security, media, robotics, and medical image analysis. The company aims to establish a "universal visual index of the world" as a global standard for machines to comprehend images. Cortica's headquarters and research and development center are located in Israel, employing a team of over 80 AI researchers and experts from elite military intelligence backgrounds.
RxLightning
Series A in 2023
RxLightning is a digital platform that focuses on improving access to specialty medications for patients. By automating and streamlining the traditionally complex manual enrollment process, RxLightning facilitates faster initiation of therapy across various therapeutic areas, including addiction medicine, cardiology, endocrinology, and dermatology. The platform enhances communication between healthcare providers and reduces the burden of paperwork, thereby accelerating the time it takes for patients to access necessary treatments.
Censinet
Venture Round in 2023
Censinet, Inc. is a cloud-based platform provider focused on managing third-party risk for healthcare organizations. Established in 2017 and headquartered in Winchester, Massachusetts, Censinet's platform facilitates real-time assessments of risks associated with vendors and third-party providers. By connecting healthcare providers with their vendors, the platform streamlines workflows, automates manual processes, and eliminates reliance on inefficient spreadsheets. Censinet delivers continuous insights into the evolving risk profiles of vendors, enabling healthcare companies to effectively address challenges in managing third-party risks while enhancing overall cybersecurity measures.
Upfront Healthcare Services
Series C in 2022
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.
Cleerly is a healthcare company focused on transforming the management of coronary artery disease through innovative digital care pathways aimed at preventing heart attacks. By combining advanced clinical science with state-of-the-art artificial intelligence, Cleerly develops a platform that delivers actionable clinical insights for all stakeholders involved in heart care. This platform employs a non-invasive approach to analyze and characterize plaque buildup in coronary arteries, allowing healthcare providers to better identify at-risk patients and facilitate early treatment. Cleerly's data-driven solutions not only enhance the evaluation of cardiovascular disease but also aim to improve patient heart health while delivering value to the healthcare system.
Socially Determined
Series B in 2022
Socially Determined, Inc. is a technology company that specializes in risk intelligence related to social determinants of health (SDOH). Established in 2017 and headquartered in Washington, D.C., the company offers a cloud-based platform known as SocialScape. This platform utilizes social risk indices and visualizations derived from various data sources to provide insights into the dynamics of social risk. By identifying social risk drivers, Socially Determined enables organizations such as health plans, providers, life science companies, and government agencies to develop targeted intervention strategies that aim to improve health outcomes, reduce costs, and optimize utilization patterns. The company's technology facilitates the measurement and analysis of community and individual SDOH risks, allowing for a more informed approach to addressing the needs of socially and clinically complex patients.
Greater Good Health
Series A in 2022
Greater Good Health is a healthcare organization focused on enhancing access to value-based, holistic primary care, particularly in underserved and rural communities. The company operates a nurse practitioner-led model that collaborates with health plans to establish primary care practices and works with risk-bearing organizations to implement private-labeled clinical programs aimed at promoting outcomes-focused care. By providing nurse practitioners with a comprehensive suite of resources and tools, Greater Good Health empowers them to deliver quality, whole-person care to their patients. This innovative approach not only aims to improve health outcomes and patient experiences but also to reduce healthcare costs for providers and payers.
Season Health
Series A in 2022
Season Health operates a food-as-medicine platform designed to support individuals with chronic conditions by offering personalized nutrition planning. The platform combines technology with guidance from registered dietitians to provide tailored meal recommendations for breakfast, lunch, and dinner based on users' nutritional needs, food preferences, and budgets. By utilizing clinicians' food prescriptions, Season Health enables consumers to select condition-specific meals that promote better health outcomes, facilitating a healthier lifestyle in a straightforward manner. This approach not only aids users in making informed dietary choices but also enhances their overall well-being.
Activ Surgical
Series B in 2022
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, dedicated to enhancing surgical procedures through advanced technology. Established in 2014 and originally known as Omniboros Inc., the company specializes in developing a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics. Its flagship product, the Smart Tissue Autonomous Robot (STAR), is designed to improve surgical efficiency, accuracy, and patient outcomes while reducing the risk of unintended complications. Activ Surgical's innovative, patent-protected surgical software facilitates augmented reality-based and AI-driven operations, thereby enhancing surgeons' intra-operative decision-making and fostering safer surgical practices.
Burns & Levinson
Series A in 2022
Burns & Levinson is a full-service law firm established in 1960 and headquartered in Boston, Massachusetts. The firm offers a wide range of legal services to regional, national, and international clients, focusing on various practice areas including corporate law, finance, business litigation, family law, venture capital, employment, estate planning, government investigations, intellectual property, private equity, trust litigation, and real estate. Burns & Levinson serves clients across diverse sectors such as automotive, cannabis, media, energy, clean-tech, industrials, life sciences, and sports, emphasizing a client-centered and results-oriented approach in its legal representation.
Story Health
Series A in 2022
Story Health Corporation is a healthcare technology company founded in 2020 and based in Saratoga, California. The company develops intelligent embedded virtualized clinical care software tools designed to assist healthcare specialists, including neurologists and primary care physicians, in understanding medical situations and making informed clinical decisions. Story Health's platform utilizes data from high-frequency sources to enhance therapy management through virtual protocols and adaptive machine learning. By focusing on patient-centered design, Story Health aims to bridge the gap between clinical evidence and real-world patient experiences, enabling clinicians to effectively address the physiological effects of disease and therapy.
Sware specializes in providing a validation automation platform along with managed services programs designed to help companies ensure compliance with both domestic and international regulatory requirements. The company's offerings include quality management implementation and remediation, risk management, auditing and training, and computer systems validation. Through these services, Sware enables clients to achieve product efficiency and cost reduction by streamlining the systems implementation process and utilizing an integrated compliance ecosystem methodology.
Reimagine Care
Series A in 2022
Reimagine Care is a healthcare company focused on enhancing community-based oncology care through technology-enabled services. Founded in 2020 and headquartered in Nashville, Tennessee, the company aims to make high-quality cancer care more affordable and accessible for patients. Reimagine Care collaborates with healthcare systems and independent oncology practices to facilitate value-based care delivery. By offering a comprehensive technology platform alongside essential personnel and processes, the company enables the scalable and effective provision of patient-centric cancer care across various settings, including patients' homes. This approach supports the delivery of low-cost cancer treatment and supportive services, ultimately improving the overall patient experience.
Diana Health
Series A in 2022
Diana Health is a network of contemporary women's health practices focused on transforming the delivery of maternity and women's healthcare in collaboration with hospitals. The company aims to empower women by offering a personalized and comprehensive care model that places them at the center of decision-making. Diana Health provides an individualized care program that integrates clinical care, education, and wellness support, supplemented by a user-friendly technology platform designed to enhance health outcomes and streamline operations. By engaging women and families, Diana Health strives to create a better care experience and improve clinical outcomes, assisting women in preparing for their birth experiences and parenting journeys.
Convergent Dental
Series C in 2021
Convergent Dental, Inc. is a dental equipment and technology company based in Needham, Massachusetts, founded in 2011. The company specializes in developing Solea, a computer-aided CO2 laser system designed for both hard and soft tissue dental procedures. This innovative system offers a quieter and more precise cutting experience compared to traditional laser systems, enhancing patient comfort during dental surgeries. By utilizing patented technologies and advanced computer controls, Convergent Dental aims to improve the efficiency of dental treatments while transforming the overall patient experience.
Activ Surgical
Series B in 2021
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, dedicated to enhancing surgical procedures through advanced technology. Established in 2014 and originally known as Omniboros Inc., the company specializes in developing a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics. Its flagship product, the Smart Tissue Autonomous Robot (STAR), is designed to improve surgical efficiency, accuracy, and patient outcomes while reducing the risk of unintended complications. Activ Surgical's innovative, patent-protected surgical software facilitates augmented reality-based and AI-driven operations, thereby enhancing surgeons' intra-operative decision-making and fostering safer surgical practices.
Huddle Up
Series A in 2021
Huddle Up is a pediatric digital health company dedicated to supporting the growth, development, and mental health of children. Founded in 2015 and based in Madison, Wisconsin, Huddle Up transforms the care experience by emphasizing peer-to-peer interactions and specialty support. The company partners with school districts to promote academic performance and facilitate social-emotional development, while also focusing on community, equity, inclusion, and belonging. Through its personalized, outcome-driven approach, Huddle Up aims to enhance the well-being of children and adolescents, fostering healthier lives.
Genome Medical
Series C in 2021
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.
Main Street Health
Funding Round in 2021
Main Street Health is a provider of value-based, care-focused healthcare services aimed at addressing rural wellness concerns. The company's healthcare services are data-driven, and it provides partner clinics with employees, technology, critical access hospitals, community health centers, and possibilities to flourish in the care delivery model, allowing rural residents to receive the high-quality treatment they need.
Cleerly is a healthcare company focused on transforming the management of coronary artery disease through innovative digital care pathways aimed at preventing heart attacks. By combining advanced clinical science with state-of-the-art artificial intelligence, Cleerly develops a platform that delivers actionable clinical insights for all stakeholders involved in heart care. This platform employs a non-invasive approach to analyze and characterize plaque buildup in coronary arteries, allowing healthcare providers to better identify at-risk patients and facilitate early treatment. Cleerly's data-driven solutions not only enhance the evaluation of cardiovascular disease but also aim to improve patient heart health while delivering value to the healthcare system.
Current Health
Series B in 2021
Current Health Limited is a healthcare technology company based in Edinburgh, United Kingdom, that specializes in wearable devices for monitoring patient vitals. Founded in 2014 and originally known as Snap40 Limited, the company rebranded in December 2018. Current Health's devices are designed to measure critical health indicators such as oxygen saturation, respiration rate, pulse rate, temperature, motion, activity, and posture, enabling early identification of potential health issues. Their patient monitoring platform facilitates the management of patients at home by collecting and analyzing data to detect and predict health deterioration. This allows patients to share daily activities, report symptoms, and complete structured questionnaires, ultimately helping healthcare providers reduce risks and costs associated with patient care.
Carevive Systems
Series C in 2021
Carevive Systems, Inc. is a healthcare technology company that specializes in enhancing cancer care delivery through its innovative platform. The company offers Carevive PROmpt, a comprehensive software solution designed for treatment planning, patient engagement, symptom management, and survivorship care. This platform includes features such as electronic patient-reported outcomes (ePRO), care coordination tools, and analytics that help oncology practices adapt to value-based care models. Carevive Systems also provides a Risk Stratification model to identify at-risk patients and develops symptom management plans based on clinical data and evidence-based guidelines. Founded in 2013 and based in North Miami, Florida, Carevive Systems aims to improve clinical outcomes and patient experiences by delivering personalized and continuously updated cancer care plans.
Diameter Health
Series B in 2020
Diameter Health, Inc. is a technology company that specializes in developing software solutions for healthcare organizations. Founded in 2013 and headquartered in Farmington, Connecticut, with an additional office in Wellesley, Massachusetts, the company focuses on enhancing the quality and interoperability of patient information. Its flagship product, Fusion, facilitates intelligent data exchange by normalizing and cleansing data from certified Electronic Health Records (EHRs), making it suitable for clinical use and analytics. Diameter Health also offers various other solutions, including Data Dashboard, which provides data quality ratings and dashboards for clinical documentation, and a Payer Edition for generating standardized supplemental reporting data. Additionally, the company provides tools for automatic data updates and scalable hosting solutions. Diameter Health serves a diverse clientele that includes government entities, health information exchanges, payers, healthcare IT vendors, life insurers, and health systems.
Upfront Healthcare Services
Series B in 2020
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.
Xealth
Venture Round in 2020
Xealth Inc. is a digital health company that has developed a comprehensive platform enabling clinicians to integrate, prescribe, and monitor various digital health tools and programs directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, Xealth's platform allows care teams to efficiently order digital health solutions for patients, facilitating seamless communication through email or patient portals. The platform also provides functionality for monitoring patient engagement and analyzing the impact of these tools on patient outcomes. Additionally, Xealth supports non-clinical services, such as ride-sharing and food delivery, enhancing the overall patient experience and promoting greater utilization of digital health resources.
Activ Surgical
Venture Round in 2020
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, dedicated to enhancing surgical procedures through advanced technology. Established in 2014 and originally known as Omniboros Inc., the company specializes in developing a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics. Its flagship product, the Smart Tissue Autonomous Robot (STAR), is designed to improve surgical efficiency, accuracy, and patient outcomes while reducing the risk of unintended complications. Activ Surgical's innovative, patent-protected surgical software facilitates augmented reality-based and AI-driven operations, thereby enhancing surgeons' intra-operative decision-making and fostering safer surgical practices.
Genome Medical
Series B in 2020
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.
SilverCloud Health
Series B in 2020
SilverCloud Health, established in 2011, is a digital health company that develops and provides online therapeutic solutions via tailored clinical programs. Headquartered in Boston, Massachusetts, with offices in Dublin, Ireland, and London, UK, the company's SilverCloud platform offers evidence-based, supported digital therapies to various healthcare sectors. It aims to increase client/patient engagement and reduce program dropout rates, as demonstrated by a three-fold improvement in these metrics compared to leading online therapeutic products.
Carevive Systems
Series C in 2020
Carevive Systems, Inc. is a healthcare technology company that specializes in enhancing cancer care delivery through its innovative platform. The company offers Carevive PROmpt, a comprehensive software solution designed for treatment planning, patient engagement, symptom management, and survivorship care. This platform includes features such as electronic patient-reported outcomes (ePRO), care coordination tools, and analytics that help oncology practices adapt to value-based care models. Carevive Systems also provides a Risk Stratification model to identify at-risk patients and develops symptom management plans based on clinical data and evidence-based guidelines. Founded in 2013 and based in North Miami, Florida, Carevive Systems aims to improve clinical outcomes and patient experiences by delivering personalized and continuously updated cancer care plans.
Socially Determined
Series A in 2019
Socially Determined, Inc. is a technology company that specializes in risk intelligence related to social determinants of health (SDOH). Established in 2017 and headquartered in Washington, D.C., the company offers a cloud-based platform known as SocialScape. This platform utilizes social risk indices and visualizations derived from various data sources to provide insights into the dynamics of social risk. By identifying social risk drivers, Socially Determined enables organizations such as health plans, providers, life science companies, and government agencies to develop targeted intervention strategies that aim to improve health outcomes, reduce costs, and optimize utilization patterns. The company's technology facilitates the measurement and analysis of community and individual SDOH risks, allowing for a more informed approach to addressing the needs of socially and clinically complex patients.
Genome Medical
Series B in 2019
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.
Censinet, Inc. is a cloud-based platform provider focused on managing third-party risk for healthcare organizations. Established in 2017 and headquartered in Winchester, Massachusetts, Censinet's platform facilitates real-time assessments of risks associated with vendors and third-party providers. By connecting healthcare providers with their vendors, the platform streamlines workflows, automates manual processes, and eliminates reliance on inefficient spreadsheets. Censinet delivers continuous insights into the evolving risk profiles of vendors, enabling healthcare companies to effectively address challenges in managing third-party risks while enhancing overall cybersecurity measures.
Diameter Health
Series A in 2019
Diameter Health, Inc. is a technology company that specializes in developing software solutions for healthcare organizations. Founded in 2013 and headquartered in Farmington, Connecticut, with an additional office in Wellesley, Massachusetts, the company focuses on enhancing the quality and interoperability of patient information. Its flagship product, Fusion, facilitates intelligent data exchange by normalizing and cleansing data from certified Electronic Health Records (EHRs), making it suitable for clinical use and analytics. Diameter Health also offers various other solutions, including Data Dashboard, which provides data quality ratings and dashboards for clinical documentation, and a Payer Edition for generating standardized supplemental reporting data. Additionally, the company provides tools for automatic data updates and scalable hosting solutions. Diameter Health serves a diverse clientele that includes government entities, health information exchanges, payers, healthcare IT vendors, life insurers, and health systems.
Verata Health (Now Part of Olive)
Series A in 2019
Verata Health, now part of Olive, was established in 2017 and is headquartered in Bloomington, Minnesota, with additional offices in Minneapolis, Boston, and Orlando. The company specializes in developing artificial intelligence-based software solutions aimed at improving the prior authorization process for healthcare providers and payers. Its platform synthesizes clinical documentation and medical necessity rules to provide real-time decision recommendations, thereby streamlining manual tasks and enhancing efficiency. By removing barriers associated with prior authorization, Verata Health's technology enables healthcare providers, private practices, and pharmacies to take control of their revenue cycles, reduce write-offs, and ensure that patients receive timely care. The company has gained trust from health systems and providers across the country for its innovative approach to modernizing the healthcare authorization process.
First Light Diagnostics
Series A in 2019
First Light Diagnostics Inc. is a medical diagnostics company focused on developing automated products for the rapid detection of pathogens responsible for healthcare-associated infections. Based in Chelmsford, Massachusetts, the company offers a benchtop MultiPath analyzer, which is designed for hospital clinical microbiology laboratories and can identify both resistant and sensitive strains of Staphylococcus aureus, as well as various toxins and viruses. Their innovative diagnostic solutions address the increasing demand for accurate and cost-effective testing, which has been shown to significantly reduce hospital infection rates. First Light's proprietary MultiPath detection technology combines the performance of advanced laboratory tests with enhanced affordability and user-friendliness. By providing antimicrobial susceptibility tests that deliver results within hours, the company enables healthcare professionals to administer appropriate antibiotic treatments quickly, ultimately saving lives, reducing healthcare costs, and improving antibiotic stewardship. First Light Diagnostics was incorporated in 2006 and was formerly known as First Light Biosciences Inc. before its name change in January 2019.
Cyft
Venture Round in 2019
Cyft, Inc. is a Boston-based company that specializes in developing a cloud-based predictive analytics platform tailored for the healthcare sector. Founded in 2015, Cyft collaborates with care organizations, including providers, Accountable Care Organizations (ACOs), health plans, and life sciences companies, to enhance care management for populations with chronic or complex health needs, behavioral health issues, and dual eligibility. By leveraging a wide array of data sources, such as claims, health risk assessments, and case management notes, Cyft empowers Medicaid plans to implement targeted interventions that optimize health outcomes and financial performance. The company combines advanced machine learning and natural language processing technologies with a deep understanding of healthcare processes, ensuring that interventions are effectively integrated into existing workflows. This approach has enabled Cyft's partners to achieve significant cost savings and improve member satisfaction and retention through data-driven care management strategies.
MachineMetrics
Series A in 2018
MachineMetrics Inc. is a company that specializes in developing real-time production monitoring software for various manufacturing sectors, including aerospace, automotive, and medical devices. Founded in 2014 and headquartered in Northampton, Massachusetts, the company offers an automated cloud solution that collects, analyzes, and visualizes machine data. This platform provides manufacturers with real-time dashboards and notifications, enabling them to address production issues promptly and make informed decisions. By simplifying the integration of Internet of Things (IoT) technology on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving performance by over 20% for its clients. The company's focus on delivering deep analytics and predictive insights allows clients to digitize legacy processes and maximize profitability.
IntelyCare
Series A in 2018
IntelyCare, Inc. is a healthcare staffing solutions company based in Quincy, Massachusetts, founded in 2014. It provides an advanced digital workforce augmentation platform that combines a gig-model application with data science to address staffing challenges in the healthcare sector. The platform allows post-acute healthcare facilities to optimize their staffing levels by matching nursing professionals with available shifts, thereby filling positions at a rate significantly higher than the industry average. It also empowers nurses and nursing assistants to create flexible schedules and choose their preferred shifts, helping to reduce burnout and improve retention rates. In addition, IntelyCare's platform incorporates artificial intelligence to automate scheduling and manage staffing needs efficiently, while also ensuring that healthcare providers can verify the licensure status of nursing staff easily. The company serves a diverse range of clients, including nurses, home care agencies, assisted living facilities, long-term care institutions, and rehabilitation hospitals.
Sansoro Health
Series B in 2018
Sansoro Health, Inc. is a healthcare technology company based in Minneapolis, Minnesota, that specializes in integration software for electronic medical record (EMR) platforms. Founded in 2014, the company offers its flagship product, Emissary, which facilitates EMR interoperability through universal application programming interfaces (APIs) and a unified data model. Emissary allows for the integrated display of patient charts from multiple EMRs, enabling real-time clinical analytics alongside web portals and mobile applications. This middleware can be quickly implemented, often within hours, and connects seamlessly with existing EMR systems, significantly reducing costs and operational challenges for healthcare providers. Additionally, Sansoro Health provides tools for monitoring and managing the integration environment, which include advanced security and auditing features, ensuring a streamlined data exchange between electronic health records and clinical administrative applications.
Oculus Health
Series A in 2017
Oculus Health, Inc. operates a chronic care management platform designed to enhance the connection between healthcare providers and patients. Founded in 2014 and based in Irving, Texas, the company offers a comprehensive suite of services that includes shared care plans, access to medical assistants via online and phone support, and real-time monitoring of enrolled patients. Oculus Health integrates data from various healthcare sources, such as hospitals and laboratories, to facilitate seamless information exchange among care teams. The platform also features user-friendly web and mobile applications, remote monitoring capabilities, and patient engagement solutions. By providing transparent care plans, personalized health coaching, and a reminder system, Oculus Health aims to empower individuals in managing their health proactively and improving overall patient outcomes while supporting providers in navigating the evolving healthcare landscape.
MachineMetrics
Seed Round in 2016
MachineMetrics Inc. is a company that specializes in developing real-time production monitoring software for various manufacturing sectors, including aerospace, automotive, and medical devices. Founded in 2014 and headquartered in Northampton, Massachusetts, the company offers an automated cloud solution that collects, analyzes, and visualizes machine data. This platform provides manufacturers with real-time dashboards and notifications, enabling them to address production issues promptly and make informed decisions. By simplifying the integration of Internet of Things (IoT) technology on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving performance by over 20% for its clients. The company's focus on delivering deep analytics and predictive insights allows clients to digitize legacy processes and maximize profitability.
Connotate
Series B in 2016
Connotate Technologies, Inc., established in 2000 and headquartered in Los Gatos, California, specializes in web data extraction. It offers a platform that transforms web data and content into valuable information assets, serving a wide range of industries including financial information providers, market research companies, and government customers. Connotate's patented intelligent Agent technology enables both business users and programmers to efficiently create data sets, applications, and content products, leading to increased productivity, reduced costs, and improved decision-making. The company operates as a subsidiary of Import.io Ltd.
Carevive Systems
Series B in 2016
Carevive Systems, Inc. is a healthcare technology company that specializes in enhancing cancer care delivery through its innovative platform. The company offers Carevive PROmpt, a comprehensive software solution designed for treatment planning, patient engagement, symptom management, and survivorship care. This platform includes features such as electronic patient-reported outcomes (ePRO), care coordination tools, and analytics that help oncology practices adapt to value-based care models. Carevive Systems also provides a Risk Stratification model to identify at-risk patients and develops symptom management plans based on clinical data and evidence-based guidelines. Founded in 2013 and based in North Miami, Florida, Carevive Systems aims to improve clinical outcomes and patient experiences by delivering personalized and continuously updated cancer care plans.
Medcrypt
Seed Round in 2016
MedCrypt Inc. is a cybersecurity company specializing in the protection of medical devices. Founded in 2016 and based in Encinitas, California, MedCrypt provides data security solutions for a wide range of medical devices, including implantable devices like pacemakers and various surgical robots. The company's platform offers data security as a service to medical device original equipment manufacturers (OEMs), enabling them to implement essential security features quickly and efficiently. These features include user authentication, data encryption, and transaction monitoring to detect potential malicious behavior. By integrating security capabilities into medical devices with minimal code, MedCrypt allows engineers to focus on developing innovative clinical functionalities while ensuring the safety and integrity of device operations.
Diameter Health
Series A in 2016
Diameter Health, Inc. is a technology company that specializes in developing software solutions for healthcare organizations. Founded in 2013 and headquartered in Farmington, Connecticut, with an additional office in Wellesley, Massachusetts, the company focuses on enhancing the quality and interoperability of patient information. Its flagship product, Fusion, facilitates intelligent data exchange by normalizing and cleansing data from certified Electronic Health Records (EHRs), making it suitable for clinical use and analytics. Diameter Health also offers various other solutions, including Data Dashboard, which provides data quality ratings and dashboards for clinical documentation, and a Payer Edition for generating standardized supplemental reporting data. Additionally, the company provides tools for automatic data updates and scalable hosting solutions. Diameter Health serves a diverse clientele that includes government entities, health information exchanges, payers, healthcare IT vendors, life insurers, and health systems.
lifeIMAGE
Series D in 2015
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.
MachineMetrics
Venture Round in 2015
MachineMetrics Inc. is a company that specializes in developing real-time production monitoring software for various manufacturing sectors, including aerospace, automotive, and medical devices. Founded in 2014 and headquartered in Northampton, Massachusetts, the company offers an automated cloud solution that collects, analyzes, and visualizes machine data. This platform provides manufacturers with real-time dashboards and notifications, enabling them to address production issues promptly and make informed decisions. By simplifying the integration of Internet of Things (IoT) technology on the shop floor, MachineMetrics enhances manufacturing efficiency, reportedly improving performance by over 20% for its clients. The company's focus on delivering deep analytics and predictive insights allows clients to digitize legacy processes and maximize profitability.
lifeIMAGE
Venture Round in 2015
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.
Convergent Dental
Venture Round in 2015
Convergent Dental, Inc. is a dental equipment and technology company based in Needham, Massachusetts, founded in 2011. The company specializes in developing Solea, a computer-aided CO2 laser system designed for both hard and soft tissue dental procedures. This innovative system offers a quieter and more precise cutting experience compared to traditional laser systems, enhancing patient comfort during dental surgeries. By utilizing patented technologies and advanced computer controls, Convergent Dental aims to improve the efficiency of dental treatments while transforming the overall patient experience.
Convergent Dental
Venture Round in 2014
Convergent Dental, Inc. is a dental equipment and technology company based in Needham, Massachusetts, founded in 2011. The company specializes in developing Solea, a computer-aided CO2 laser system designed for both hard and soft tissue dental procedures. This innovative system offers a quieter and more precise cutting experience compared to traditional laser systems, enhancing patient comfort during dental surgeries. By utilizing patented technologies and advanced computer controls, Convergent Dental aims to improve the efficiency of dental treatments while transforming the overall patient experience.
lifeIMAGE
Series B in 2011
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.
MedVentive
Series C in 2010
MedVentive is a technology solutions provider specializing in healthcare delivery systems, payers, and employer coalitions. Founded in 1997 by physicians, the company focuses on developing innovative solutions aimed at enhancing the quality of care while reducing associated costs. MedVentive's offerings include quality management, clinical integration, pharmacy management, and point-of-care decision support. Additionally, the company provides a pay-for-performance solution that calculates and tracks clinical measures, delivering tailored patient intervention recommendations. Through these services, MedVentive enables physician groups and integrated delivery systems to implement meaningful changes in their healthcare practices.
Extreme Reach
Series B in 2010
Extreme Reach specializes in content production and creative asset management within the media, entertainment, and advertising sectors. The company offers a comprehensive platform that addresses challenges related to content proliferation and audience fragmentation, providing services such as creative asset management, talent and rights management, and payment solutions. Its flagship product, AdBridge™, streamlines the complex workflows necessary for modern advertising, integrating various processes to enhance campaign execution. With over 200,000 users and managing nearly four million creative assets, Extreme Reach supports leading brands, studios, agencies, and performers by simplifying operational tasks. Additionally, the company is recognized as a leader in commercial talent and rights management and plays a significant role in payroll services for the industry, processing approximately $2 billion annually. By continually innovating its platform, Extreme Reach enables clients to adapt and thrive in an evolving marketplace.
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.
Solais Lighting
Series A in 2010
Solais Lighting is a manufacturing company that specializes in innovative LED lighting solutions aimed at enhancing various environments, including retail, commercial, and hospitality spaces. As a leader in LED lamp technology, Solais is committed to developing energy-efficient products that utilize active cooling to extend lamp life and maintain high performance without compromising aesthetics. The company boasts a dedicated executive team with extensive expertise across solid-state lighting research, product development, manufacturing, and distribution. With strong financial backing and a global manufacturing partnership, Solais Lighting is well-equipped to meet the rising demand for advanced lighting solutions while maintaining its focus on innovation and responsiveness to market needs.
GateRocket
Series A in 2009
GateRocket, Inc. provides verification and debugging solutions for FPGAs. It offers RocketDrive, a device native verification system for complex FPGAs, which accelerates verification throughput and identifies problems with IP blocks, pin-outs, and tool chain anomalies. The company also provides RocketVision, a FPGA debug solution that automates test point insertion and detects differences between RTL and FPGA devices. The company was incorporated in 2003 and is headquartered in Bedford, Massachusetts.
lifeIMAGE
Series A in 2009
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.
Health Guru Media
Series C in 2009
Healthguru.com is the destination site for health video on the web with 99 million views per month (comScore Video Metrix, August). Our unique approach to health education was developed specifically for the video audience and is differentiated in three key ways: - Category Focus: Healthguru.com focuses on the health topics that matter most to today's audience, including: diet and fitness, mental & emotional health, sexual health, pregnancy, baby health, drugs & alcohol, as well as information on more than 125 different health conditions. - Medium: The modern health consumer seeks out an immersive, rich media experience on the web, and video has proven to be a more engaging medium. Healthguru.com has the largest health video library online, and interactive applications to offer our audience the experience it expects. - Editorial Approach: World-class information providers know that creating truly engaging content is the way to ensure that information becomes learning. That's why Healthguru.com is dedicated to making our content as interesting and, when relevant, entertaining, as it is useful. All Healthguru.com content is created or selected by our editorial team and is rigorously reviewed for medical accuracy, objectivity and balance. While we do accept advertising on our site and may distribute content via third party sites, Healthguru.com does not endorse products, services or companies.
MedVentive
Series C in 2009
MedVentive is a technology solutions provider specializing in healthcare delivery systems, payers, and employer coalitions. Founded in 1997 by physicians, the company focuses on developing innovative solutions aimed at enhancing the quality of care while reducing associated costs. MedVentive's offerings include quality management, clinical integration, pharmacy management, and point-of-care decision support. Additionally, the company provides a pay-for-performance solution that calculates and tracks clinical measures, delivering tailored patient intervention recommendations. Through these services, MedVentive enables physician groups and integrated delivery systems to implement meaningful changes in their healthcare practices.
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.
Extreme Reach
Series A in 2009
Extreme Reach specializes in content production and creative asset management within the media, entertainment, and advertising sectors. The company offers a comprehensive platform that addresses challenges related to content proliferation and audience fragmentation, providing services such as creative asset management, talent and rights management, and payment solutions. Its flagship product, AdBridge™, streamlines the complex workflows necessary for modern advertising, integrating various processes to enhance campaign execution. With over 200,000 users and managing nearly four million creative assets, Extreme Reach supports leading brands, studios, agencies, and performers by simplifying operational tasks. Additionally, the company is recognized as a leader in commercial talent and rights management and plays a significant role in payroll services for the industry, processing approximately $2 billion annually. By continually innovating its platform, Extreme Reach enables clients to adapt and thrive in an evolving marketplace.
Qteros, Inc. is a biofuels company based in Amherst, Massachusetts, that specializes in developing technologies for converting nonfood biomass into cellulosic ethanol, a sustainable transportation fuel. Founded in 1996 and formerly known as SunEthanol, Qteros focuses on its proprietary Q Microbe, which efficiently extracts sugars from various biomass resources such as trees and plants. This innovative approach combines enzymatic hydrolysis and fermentation, making the conversion process cleaner and closer to carbon neutrality. By harnessing renewable microbial technology, Qteros aims to produce locally sourced transportation fuel that is not only environmentally friendly but also economically viable, positioning itself as a leader in the biofuels industry.
GateRocket
Series A in 2008
GateRocket, Inc. provides verification and debugging solutions for FPGAs. It offers RocketDrive, a device native verification system for complex FPGAs, which accelerates verification throughput and identifies problems with IP blocks, pin-outs, and tool chain anomalies. The company also provides RocketVision, a FPGA debug solution that automates test point insertion and detects differences between RTL and FPGA devices. The company was incorporated in 2003 and is headquartered in Bedford, Massachusetts.
MedVentive
Series B in 2008
MedVentive is a technology solutions provider specializing in healthcare delivery systems, payers, and employer coalitions. Founded in 1997 by physicians, the company focuses on developing innovative solutions aimed at enhancing the quality of care while reducing associated costs. MedVentive's offerings include quality management, clinical integration, pharmacy management, and point-of-care decision support. Additionally, the company provides a pay-for-performance solution that calculates and tracks clinical measures, delivering tailored patient intervention recommendations. Through these services, MedVentive enables physician groups and integrated delivery systems to implement meaningful changes in their healthcare practices.
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.
Qteros, Inc. is a biofuels company based in Amherst, Massachusetts, that specializes in developing technologies for converting nonfood biomass into cellulosic ethanol, a sustainable transportation fuel. Founded in 1996 and formerly known as SunEthanol, Qteros focuses on its proprietary Q Microbe, which efficiently extracts sugars from various biomass resources such as trees and plants. This innovative approach combines enzymatic hydrolysis and fermentation, making the conversion process cleaner and closer to carbon neutrality. By harnessing renewable microbial technology, Qteros aims to produce locally sourced transportation fuel that is not only environmentally friendly but also economically viable, positioning itself as a leader in the biofuels industry.
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.
MedVentive
Series A in 2006
MedVentive is a technology solutions provider specializing in healthcare delivery systems, payers, and employer coalitions. Founded in 1997 by physicians, the company focuses on developing innovative solutions aimed at enhancing the quality of care while reducing associated costs. MedVentive's offerings include quality management, clinical integration, pharmacy management, and point-of-care decision support. Additionally, the company provides a pay-for-performance solution that calculates and tracks clinical measures, delivering tailored patient intervention recommendations. Through these services, MedVentive enables physician groups and integrated delivery systems to implement meaningful changes in their healthcare practices.
Optasite engages in the acquisition and development of telecommunications tower sites in the United States. It offers wireless consulting services. The company's services also include site leasing and colocation, tower acquisition, and site development. It serves broadband wireless providers, including wireless carriers, as well as other customers in the telecommunications industry, such as the FCC licensed carriers, government agencies, public safety organizations, private enterprises, and two-way radio services. Optasite, Inc. was formerly known as Pinnacle Site Development, Inc
GetWellNetwork
Series B in 2005
GetWellNetwork, Inc. is a Bethesda, Maryland-based company that specializes in developing precision engagement software solutions aimed at enhancing patient involvement in the healthcare process. Founded in 1999 by Michael O’Neil Jr., the company provides a range of interactive tools tailored for hospitals, including the GetWell Patient Care solution, which integrates various resources to activate patient participation. Its offerings encompass digital check-in systems, entertainment options, and personalized education through a library of condition-specific content. The GetWellNetwork platform utilizes predefined workflows, known as Patient Pathways, to deliver educational materials and engage patients in their care journey. This approach facilitates real-time monitoring and documentation of patient progress, enabling healthcare providers to customize experiences based on individual needs. GetWellNetwork primarily serves healthcare providers, pediatric hospitals, and government organizations, striving to improve patient care outcomes through enhanced engagement and education.
Verax Biomedical
Series B in 2005
Verax Biomedical, Incorporated is a medical products company headquartered in Marlborough, Massachusetts, established in 1999. The company specializes in developing rapid tests for detecting bacterial contaminants in blood cells and tissues intended for transplantation and cellular therapies. Recognizing the unique challenges posed by bacterial contamination—especially since bacteria can multiply in storage conditions, leading to significant risks during transfusions and transplants—Verax Biomedical has created innovative solutions to address this critical health concern. Its product line includes platelet and red cell pan genera detection tests that identify common antigens present on both gram-positive and gram-negative bacteria. By enabling blood banks to detect bacterial contamination effectively, Verax Biomedical plays an essential role in enhancing the safety of blood transfusions and transplants.
Aircuity, Inc. is a manufacturer of intelligent measurement solutions aimed at enhancing energy efficiency and indoor environmental quality in various settings, including commercial offices, educational institutions, healthcare facilities, and sports arenas. Founded in 2000 and headquartered in Newton, Massachusetts, the company offers a range of products, including the Sensor Suite, which utilizes a scalable architecture for monitoring multiple indoor environmental parameters. Their offerings also include specialized sensors for evaluating conditions such as temperature and air quality, along with a comprehensive Information Management System for network oversight. Aircuity's technology focuses on demand control ventilation, allowing for real-time adjustments based on internal conditions, thereby optimizing operational performance and safety. The company markets its products through various sales channels across numerous countries, ensuring a global reach in supporting energy conservation and improving indoor environments.
Aircuity, Inc. is a manufacturer of intelligent measurement solutions aimed at enhancing energy efficiency and indoor environmental quality in various settings, including commercial offices, educational institutions, healthcare facilities, and sports arenas. Founded in 2000 and headquartered in Newton, Massachusetts, the company offers a range of products, including the Sensor Suite, which utilizes a scalable architecture for monitoring multiple indoor environmental parameters. Their offerings also include specialized sensors for evaluating conditions such as temperature and air quality, along with a comprehensive Information Management System for network oversight. Aircuity's technology focuses on demand control ventilation, allowing for real-time adjustments based on internal conditions, thereby optimizing operational performance and safety. The company markets its products through various sales channels across numerous countries, ensuring a global reach in supporting energy conservation and improving indoor environments.
Optasite engages in the acquisition and development of telecommunications tower sites in the United States. It offers wireless consulting services. The company's services also include site leasing and colocation, tower acquisition, and site development. It serves broadband wireless providers, including wireless carriers, as well as other customers in the telecommunications industry, such as the FCC licensed carriers, government agencies, public safety organizations, private enterprises, and two-way radio services. Optasite, Inc. was formerly known as Pinnacle Site Development, Inc
Medical Metrx Solutions
Series B in 2003
Medical Metrx Solutions, Inc. (formerly Medical Media Systems) is a medical technology and services company providing diagnostic quality 3-D virtual models of patient anatomy built from CT and MR scan data using the company’s proprietary modeling software. The company’s models — which contain more precise quantitative measurement information than competitors’ offerings — are provided to interventional radiologists and vascular surgeons who use them for pre-operative planning and post-operative surveillance of their patients’ conditions. The company was acquired by AIG Altaris Health Partners in 2005.
Protedyne
Venture Round in 2001
Protedyne is a subsidiary of Laboratory Corporation of America, specializing in the development of laboratory automation systems aimed at enhancing efficiency in the pharmaceutical and biotech sectors. The company employs industrial automation design principles to create advanced robotic systems that integrate powerful hardware and a comprehensive software infrastructure for data management and process tracking. Protedyne’s solutions include an enclosed platform featuring a 4-axis robotic arm, which facilitates flexible configurations and optimizes workspace utilization. By implementing these automation technologies, Protedyne enables laboratories to streamline their operations and improve productivity in diagnostic testing and related processes. The company is also ISO 13485:2003 Registered, ensuring adherence to quality management standards in its operations.